Screener
CytomX Therapeutics CTMX Total Current Assets
Total Current Assets at other companies
Other financials
Where this comes from
Reported directly by CytomX Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:AssetsCurrent.
The source filing: CytomX Therapeutics’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 4:05 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-337950
| Line item | June 30, 2026 | December 31, 2025 |
|---|---|---|
| Restricted cash | 917 | — |
| Accounts receivable | 37,494 | 2,013 |
| Prepaid expenses and other current assets | 4,464 | 4,856 |
| Total current assets | 373,155 | 143,921 |
| Property and equipment, net | 1,079 | 1,304 |
| Intangible assets, net | 365 | 438 |
| Goodwill | 949 | 949 |
| Restricted cash | 610 | 1,527 |
Item 1. Condensed Financial Statements (Unaudited)
FAQ
- What is CytomX Therapeutics's total current assets?
- CytomX Therapeutics (CTMX) reported total current assets of $373.16M in Q2 2026.
- How has CytomX Therapeutics's total current assets changed year-over-year?
- CytomX Therapeutics's total current assets increased by 126.7% year-over-year, from $164.62M to $373.16M.
- What is the long-term trend for CytomX Therapeutics's total current assets?
- Over 5 years (2020 to 2025), CytomX Therapeutics's total current assets has grown at a -15.0% compound annual growth rate (CAGR), from $324.01M to $143.92M.
- What does total current assets mean?
- The sum of all assets expected to be converted to cash or consumed within one year — cash, receivables, inventory, and prepaid expenses.
Ask your AI about CytomX Therapeutics's total current assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude